Advertisement
Home »

Factors Associated With Oral Anticoagulant Use in Patients With Atrial Fibrillation and Mental Disorders.

Jan 08, 2024

ABOUT THE EXPERTS

  • Dina Farran

    Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, United Kingdom.

    Corresponding Author: Dina Farran, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, 16 De Crespigny Park, London SE5 8AB, UK (dina.1.farran@kcl.ac.uk).

    Matthew Broadbent

    South London and Maudsley NHS Foundation Trust, London, United Kingdom.

    Aikaterini Dima

    Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, United Kingdom.

    South London and Maudsley NHS Foundation Trust, London, United Kingdom.

    Mark Ashworth

    School of Life Course and Population Sciences, King’s College London, London, United Kingdom.

    Fiona Gaughran

    Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, United Kingdom.

    South London and Maudsley NHS Foundation Trust, London, United Kingdom.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement